FDA records by company
Warning letters, inspection outcomes, recalls, complete response letters and the clinical holds companies disclose to the SEC. One page per record, each linked to the agency's own. Looking for a company? Search the directory, or check a manufacturer's whole record with the free CDMO FDA inspection lookup.
FDA warning letters
- 2026-11-10FDA warning letter to Carive Imports Inc.Foreign Supplier Verification Program (FSVP)
- 2026-11-10FDA warning letter to Tianjin Healthcare Medical Technology Co., Ltd.Refusal to Provide Access to and Copying of Records
- 2026-11-10FDA warning letter to Peakopia ProduceForeign Supplier Verification Program (FSVP)
- 2026-11-10FDA warning letter to Penn Herb Company, Ltd.CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated
- 2026-11-10FDA warning letter to Mseafood CorporationForeign Supplier Verification Program (FSVP)
- 2026-11-10FDA warning letter to Chongqing Qiancan Technology Co., Ltd.CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
FDA inspection classifications
- 2026-10-29FDA inspection of Texas Life Connect: NAINo action indicated
- 2026-10-29FDA inspection of Kindbody Newport Beach: NAINo action indicated
- 2026-10-28FDA inspection of Cogstate Inc.: NAINo action indicated
- 2026-10-28FDA inspection of CSL Plasma Inc.: NAINo action indicated
- 2026-10-28FDA inspection of Northern Illinois Blood Bank Inc.: NAINo action indicated
- 2026-10-28FDA inspection of CSL Plasma Inc.: NAINo action indicated
FDA recalls
- 2026-11-04Class II recall by Pentax of America IncPENTAX Medical Ultrasound Endoscope. Model Number. EG-3270UK.Class II
- 2026-11-04Class II recall by ABC Compounding Co., Inc.Spurrier, Antimicrobial Hand Soap, Net Contents: 1 Gallon (3.8 L), Manufactured by: ABC Compounding Co., Inc., 2600 Dogwood Dr., Conyers, GA…Class II
- 2026-11-04Class II recall by PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Philips Azurion 3 M12. Model Numbers: 722063, 722221.Class II
- 2026-11-04Class II recall by Pentax of America IncPENTAX Medical Water bottle assembly. Model Number. OS-H5.Class II
- 2026-11-04Class II recall by PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Philips Azurion 7 B20. Model Numbers: 722068, 722226.Class II
- 2026-11-04Class II recall by Safecor Health, LLCMetoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079…Class II
FDA complete response letters
- 2026-08-07Complete response letter to ITM Solucin GmbHNDA 218705
- 2026-07-21Complete response letter to Apiject Systems Corp.NDA 219107
Clinical holds in SEC filings
- 2026-11-05REGENXBIO Inc.: SEC 8-K mentions a clinical hold
- 2026-10-23Traws Pharma, Inc.: SEC 8-K mentions a clinical hold
- 2026-10-06ROCKET PHARMACEUTICALS, INC.: SEC 8-K mentions a clinical hold
- 2026-09-24Glucotrack, Inc.: SEC 8-K mentions a clinical hold
- 2026-09-22Alaunos Therapeutics, Inc.: SEC 8-K mentions a clinical hold
- 2026-09-10Biohaven Ltd.: SEC 8-K mentions a clinical hold
Questions
Search the company in the directory or type its name into the free CDMO FDA inspection lookup. Each company page lists the inspection classifications, warning letters and recalls FDA has published that name it, and each record page states what FDA published with a link to the agency's own posting. Approve Suite reads FDA's warning-letter listing every six hours, the inspection Data Dashboard daily and the enforcement reports every six hours.
A classification is FDA's rating of one inspection: NAI (no action indicated), VAI (voluntary action indicated) or OAI (official action indicated). A warning letter is a separate step FDA can take after an OAI inspection, or on other evidence: a formal notice that the agency found significant violations and expects a written response, normally within 15 working days. Most inspections end without a letter; a letter usually follows an OAI.
FDA posts an inspection's classification on its Data Dashboard only after its review of the inspection is complete, which is typically a few months after the inspection ended and can be longer. Warning letters are posted to FDA's listing in weekly batches, usually within a few weeks of the letter's date. Recalls appear in the weekly enforcement report, one to three weeks after the firm began the recall.
No. FDA does not publish most Form 483s; they reach the public through a Freedom of Information Act request or when a company discloses one. These pages show what FDA publishes: the inspection's classification, the CFR sections cited where the Data Dashboard lists them, and any warning letter that follows.
No. Approve Suite is an independent product that reads records FDA publishes and links to each one. It is not affiliated with, endorsed by or operated on behalf of FDA, and nothing here is regulatory, legal or medical advice.